Tinea Corporis Differential Diagnoses

1. Pires CA, Cruz NF, Lobato AM, Sousa PO, Carneiro FR, Mendes AM. Clinical, epidemiological, and therapeutic profile of dermatophytosis. An Bras Dermatol. 2014 Mar-Apr. 89(2):259-64. [Medline]. [Full Text].

2. Jain S, Kabi S, Swain B. Current Trends of Dermatophytosis in Eastern Odisha. J Lab Physicians. 2020 Mar. 12 (1):10-14. [Medline].

3. Yee G, Al Aboud AM. Tinea Corporis. StatPearls [Internet]. 2020 Jan. [Medline]. [Full Text].

4. Leung AK, Lam JM, Leong KF, Hon KL. Tinea corporis: an updated review. Drugs Context. 2020. 9:[Medline].

5. Adams BB. Tinea corporis gladiatorum. J Am Acad Dermatol. 2002 Aug. 47(2):286-90. [Medline].

6. Ilkit M, Saracli M, Kurdak H, et al. Clonal outbreak of Trichophyton tonsurans tinea capitis gladiatorum among wrestlers in Adana, Turkey. Med Mycol. 2009 Oct 14. [Medline].

7. Sun PL, Ho HT. Concentric rings: an unusual presentation of tinea corporis caused by Microsporum gypseum. Mycoses. 2006 Mar. 49(2):150-1. [Medline].

8. Sanchez-Castellanos ME, Mayorga-Rodriguez JA, Sandoval-Tress C, Hernandez-Torres M. Tinea incognito due to Trichophyton mentagrophytes. Mycoses. 2007 Jan. 50(1):85-7. [Medline].

9. Seyfarth F, Ziemer M, Gräser Y, Elsner P, Hipler UC. Widespread tinea corporis caused by Trichophyton rubrum with non-typical cultural characteristics--diagnosis via PCR. Mycoses. 2007. 50 Suppl 2:26-30. [Medline].

10. Leyden J. Pharmacokinetics and pharmacology of terbinafine and itraconazole. J Am Acad Dermatol. 1998 May. 38(5 Pt 3):S42-7. [Medline].

11. Singh S, Shukla P. End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients. Indian J Dermatol Venereol Leprol. 2018 Jun 8. [Medline].

12. Singh A, Masih A, Khurana A, Singh PK, Gupta M, Hagen F, et al. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene. Mycoses. 2018 Jul. 61 (7):477-484. [Medline].

13. Sardana K, Kaur R, Arora P, Goyal R, Ghunawat S. Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?. Indian Dermatol Online J. 2018 Mar-Apr. 9 (2):90-95. [Medline].

14. Mapelli ET, Borghi E, Cerri A, Sciota R, Morace G, Menni S. Tinea corporis due to Trichophyton rubrum in a Woman and Tinea capitis in her 15-Day-Old Baby: Molecular Evidence of Vertical Transmission. Mycopathologia. 2011 Oct 14. [Medline].

15. Shiraki Y, Hiruma M, Matsuba Y, et al. A case of tinea corporis caused by Arthroderma benhamiae (teleomorph of Tinea mentagrophytes) in a pet shop employee. J Am Acad Dermatol. 2006 Jul. 55(1):153-4. [Medline].

16. Placzek M, van den Heuvel ME, Flaig MJ, Korting HC. Perniosis-like tinea corporis caused by Trichophyton verrucosum in cold-exposed individuals. Mycoses. 2006 Nov. 49(6):476-9. [Medline].

17. Foster KW, Ghannoum MA, Elewski BE. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol. 2004 May. 50(5):748-52. [Medline].

18. Carod JF, Ratsitorahina M, Raherimandimby H, Hincky Vitrat V, Ravaolimalala Andrianaja V, Contet-Audonneau N. Outbreak of Tinea capitis and corporis in a primary school in Antananarivo, Madagascar. J Infect Dev Ctries. 2011 Oct 13. 5(10):732-6. [Medline].

19. Hryncewicz-Gwózdz A, Beck-Jendroschek V, Brasch J, Kalinowska K, Jagielski T. Tinea capitis and tinea corporis with a severe inflammatory response due to Trichophyton tonsurans. Acta Derm Venereol. 2011 Oct. 91(6):708-10. [Medline].

20. Seyfarth F, Goetze S, Erhard M, Burmester A, Elsner P, Hipler UC. [Infection with a rare geophilic dermatophyte.]. Hautarzt. 2009 Aug 14. [Medline].

21. Yehia MA, El-Ammawi TS, Al-Mazidi KM, Abu El-Ela MA, Al-Ajmi HS. The Spectrum of Fungal Infections with a Special Reference to Dermatophytoses in the Capital Area of Kuwait During 2000-2005: A Retrospective Analysis. Mycopathologia. 2009 Nov 17. [Medline].

22. Dhib I, Khammari I, Yaacoub A, Hadj Slama F, Ben Saïd M, Zemni R, et al. Relationship Between Phenotypic and Genotypic Characteristics of Trichophyton mentagrophytes Strains Isolated from Patients with Dermatophytosis. Mycopathologia. 2017 Jun. 182 (5-6):487-493. [Medline].

23. Ziemer M, Seyfarth F, Elsner P, Hipler UC. Atypical manifestations of tinea corporis. Mycoses. 2007. 50 Suppl 2:31-5. [Medline].

24. Kim HS, Cho BK, Oh ST. A case of tinea corporis purpurica. Mycoses. 2007 Jul. 50(4):314-6. [Medline].

25. Romano C, Massai L, Strangi R, Feci L, Miracco C, Fimiani M. Tinea corporis purpurica and onychomycosis caused by Trichophyton violaceum. Mycoses. 2009 Sep 22. [Medline].

26. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002 May 15. 65(10):2095-102. [Medline].

27. Tsunemi Y. Oral Antifungal Drugs in the Treatment of Dermatomycosis. Med Mycol J. 2016. 57 (2):J71-5. [Medline].

28. Chatterjee D, Ghosh SK, Sen S, Sarkar S, Hazra A, De R. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study. Indian J Pharmacol. 2016 Nov-Dec. 48 (6):659-664. [Medline].

29. Choudhary S, Bisati S, Singh A, Koley S. Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial. Indian J Dermatol. 2013 Nov. 58(6):457-60. [Medline]. [Full Text].

30. Liebel F, Lyte P, Garay M, Babad J, Southall MD. Anti-inflammatory and anti-itch activity of sertaconazole nitrate. Arch Dermatol Res. 2006 Sep. 298(4):191-9. [Medline].

31. Brooks, M. FDA Approves New Topical Antifungal Luliconazole 1%. Medscape Medical News. Available at http://www.medscape.com/viewarticle/814470. Accessed: November 18, 2013.

32. Luzu (luliconazole topical cream 1%) [package insert]. Bridgewater, NJ: Valeant Pharmaceuticals North America LLC. February, 2018. Available at [Full Text].

33. Mahajan S, Tilak R, Kaushal SK, Mishra RN, Pandey SS. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center. Indian J Dermatol Venereol Leprol. 2017 Jul-Aug. 83 (4):436-440. [Medline].

34. Schreuder MF, van de Kar NC, Brüggemann RJ. Drug-Drug Interactions in Treatment Using Azole Antifungal Agents. JAMA. 2016 Jun 21. 315 (23):2622. [Medline].

35. Chen S, Ran Y, Dai Y, Lama J, Hu W, Zhang C. Administration of Oral Itraconazole Capsule with Whole Milk Shows Enhanced Efficacy As Supported by Scanning Electron Microscopy in a Child with Tinea Capitis Due to Microsporum canis. Pediatr Dermatol. 2015 Oct 8. [Medline].

36. da Silva Barros ME, de Assis Santos D, Soares Hamdan J. Antifungal susceptibility testing of Trichophyton rubrum by E-test. Arch Dermatol Res. 2007 May. 299(2):107-9. [Medline].

37. Wingfield AB, Fernandez-Obregon AC, Wignall FS, Greer DL. Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole. Br J Dermatol. 2004 Jan. 150(1):119-26. [Medline].

38. Eusebio-Alpapara KMV, Dofitas BL, Balita-Crisostomo CLA, Tioleco-Ver GMS, Jandoc LE, Frez MLF. Senna (Cassia) alata (Linn.) Roxb. leaf decoction as a treatment for tinea imbricata in an indigenous tribe in Southern Philippines. Mycoses. 2020 Aug 10. [Medline].

39. Majid I, Sheikh G, Kanth F, Hakak R. Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study. Indian J Dermatol. 2016 Sep-Oct. 61 (5):529-33. [Medline].

40. Diep D, Calame A, Cohen PR. Tinea Corporis Masquerading as a Diffuse Gyrate Erythema: Case Report and a Review of Annular Lesions Mimicking a Dermatophyte Skin Infection. Cureus. 2020 Jun 30. 12 (6):e8935. [Medline].

Shweta Shukla, MD Resident Physician, Department of Dermatology, State University of New York Downstate Medical Center

Disclosure: Nothing to disclose.

Amor Khachemoune, MD Director of Mohs and Laser Surgery, Dermatopathology, Premier Dermatology, PC; Associate Program Director, Mohs Micrographic Surgery Fellowship Training Program, Co-Chief of Dermatologic Surgery, Consulting Staff Physician, Dermatology Service, VA Hospital of Brooklyn; Mohs Surgeon, Veterans Affairs Hospital of Baltimore; Chair Professor, Vitiligo Research Chair, Department of Dermatology, King Saud University; Consultant Dermatologist, Kadina Medical Center, KSA

Amor Khachemoune, MD is a member of the following medical societies: American Academy of Dermatology, American Academy of Wound Management, American College of Mohs Surgery, American Medical Association, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, French Society for Dermatology

Disclosure: Nothing to disclose.

Richard P Vinson, MD Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Texas Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

Rosalie Elenitsas, MD Herman Beerman Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System

Rosalie Elenitsas, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, American Society of Dermatopathology, Pennsylvania Academy of Dermatology

Disclosure: Received royalty from Lippincott Williams Wilkins for textbook editor.

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Janet Fairley, MD Professor and Head, Department of Dermatology, University of Iowa, Roy J and Lucille A Carver College of Medicine

Janet Fairley, MD is a member of the following medical societies: American Academy of Dermatology, American Federation for Medical Research, Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Jack L Lesher, Jr, MD Chief, Professor, Department of Internal Medicine, Section of Dermatology, Medical College of Georgia

Jack L Lesher, Jr, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, Medical Association of Georgia, Society for Investigative Dermatology, Southern Medical Association

Disclosure: Nothing to disclose.

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors Mary Elizabeth Rushing Lott, MD and Gwendolyn Zember, MD, to the development and writing of this article.

• Print this section
• Print the entire contents of
• Print the entire contents of article